MeVis Medical Solutions AGFRA:M3V 66 Days Payable is 129.76 as of Mar. 2026, which is 20% above its 10-year median of 108.26. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review. Among 607 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 82.7% on this metric.
The historical rank and industry rank for MeVis Medical Solutions AG's Days Payable or its related term are showing as below:
FRA:M3V'
s Days Payable Range Over the Past 10 Years
Min: 15.97 Med: 108.26 Max: 337.57
Current: 174.69
During the past 13 years, MeVis Medical Solutions AG's highest Days Payable was 337.57. The lowest was 15.97. And the median was 108.26.
FRA:M3V's Days Payable is ranked better than 82.7% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs FRA:M3V: 174.69
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3V vs VEEV, BTSG, TEM: Days Payable Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Days Payable distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's Days Payable falls into.
MeVis Medical Solutions AG Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG (FRA:M3V) has a Days Payable of 129.76 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MeVis Medical Solutions AG and its competitors. This is 20% above median its historical median of 108.26. Over the past decade, MeVis Medical Solutions AG's Days Payable has ranged from 15.97 to 337.57. According to the industry distribution chart, MeVis Medical Solutions AG ranks #105 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 17.3%.
Is MeVis Medical Solutions AG's Days Payable too high?
MeVis Medical Solutions AG's current Days Payable of 129.76 is 20% above median its 10-year median of 108.26. Over the past 10 years, this metric has ranged from a low of 15.97 to a high of 337.57. The Healthcare Providers & Services industry median Days Payable is 58.00. MeVis Medical Solutions AG's value of 129.76 is 123.7% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #105 out of 607 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #105 out of 607 companies for Days Payable. This places MeVis Medical Solutions AG in the top 17% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.00. MeVis Medical Solutions AG's value of 129.76 is 123.7% above this benchmark. Historically, MeVis Medical Solutions AG's own Days Payable has ranged from 15.97 to 337.57 over the past decade. While the company's 10-year median is 108.26 vs. the industry median of 58.00, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current Days Payable of 129.76 is 123.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Days Payable is 129.76, which is 20% above median its own 10-year median of 108.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Days Payable of 129.76. The stock's GF Value™ is €22.52, compared to a current price of €24.00 — trading 6.6% above its estimated fair value. The current Days Payable is 129.76, which is 20% above median its 10-year median of 108.26 and 123.7% above the Healthcare Providers & Services industry median of 58.00. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Days Payable is 129.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €24.00 is trading 6.6% above its estimated GF Value™ of €22.52.
Key valuation signals for FRA:M3V:
Days Payable: 129.76 (20% above median its 10-year median of 108.26)
GF Value™: €22.52 vs. price of €24.00 (6.6% above fair value)
Industry Position: 123.7% above the Healthcare Providers & Services median (#105 of 607)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
